FUJIFILM Diosynth Biotechnologies, a contract developer and manufacturer, has partnered with the UK’s universities of Edinburgh, Manchester and York to address challenges in bioprocessing.
Dubbed the Centre of Excellence in Bioprocessing 2.0, the initiative will link Fujifilm’s research goals with fundamental academic research and together the partners will apply for public funding from the likes of UK Research and Innovation (UKRI).
Fujifilm, which has experience developing and manufacturing recombinant biopharmaceuticals and gene therapies, has three overarching research and development priorities. These are using automation, robotics and predictive technologies to reduce the amount of wet, bench science required to meet project objectives; developing next-generation manufacturing and testing technologies using smaller, more flexible, and more automated facilities; and ‘new biology’ for the development of emerging products.
“Our aim is to link fundamental research and world-class expertise to the business needs of Fujifilm,” said Jen Vanderhoven, Vice President of Global Business Change. “We are creating an innovation engine that drives new processes, efficiencies, products and services.”
Catch up on the latest news, views and jobs from The Chemical Engineer. Below are the four latest issues. View a wider selection of the archive from within the Magazine section of this site.